NR4A1 and breast cancer: These in turn lead to hyperglycemia, hypertriglyceridemia, inflammation and insulin resistance [30], which have been shown to increase the risk of breast and colorectal cancer incidence, as well as the development of the more aggressive hormone-receptor negative sub-types of breast cancer [31, 32].